Released Title Price Sensitive Download Types
2025-01-06 08:55:00 Patient Enrolment Completed for INSIGHT-003 0 https://app.sharelinktechnologies.com/announcement-preview/asx/af62403513d58ccfdbd20a6f0526428d
    Progress Report
2025-01-22 09:02:00 Enrolment completed for Ph II trial in Soft Tissue Sarcoma 0 https://app.sharelinktechnologies.com/announcement-preview/asx/bc5d7cdcff027208cb04639a2c3ea159
    Progress Report
2025-01-31 08:27:00 Immutep Quarterly Activities Report and Appendix 4C 1 https://app.sharelinktechnologies.com/announcement-preview/asx/89f7899a443be301a212c8751db99a61
    Commitments Test Entity - Second Quarter Report
    Commitments Test Entity - Second Quarter Activity Report
2025-02-05 11:37:00 Immutep Corporate Presentation 0 https://app.sharelinktechnologies.com/announcement-preview/asx/43e801e9d57c39f42958009177daccea
    Company Presentation
2025-02-06 18:03:00 Notification of cessation of securities - IMM 0 https://app.sharelinktechnologies.com/announcement-preview/asx/6e2c330c40761e10495a51842a540a14
    Appendix 3H (Notification of cessation of securities)
2025-02-26 18:58:00 Half Yearly Report and Accounts 1 https://app.sharelinktechnologies.com/announcement-preview/asx/14fa7ee4e1f2d57b4d348c9c5f8e2cb5
    Half Yearly Report
    Half Year Audit Review
    Half Year Directors' Statement
    Half Year Accounts
    Half Year Directors' Report
2025-03-20 10:29:00 TACTI-004 trial in progress poster to be presented at ELCC 0 https://app.sharelinktechnologies.com/announcement-preview/asx/9327a9c3baf27cf0a8b9083e51cc938c
    Company Administration - Other
2025-03-25 08:38:00 First patient dosed in phase 3 TACTI-004 lung cancer trial 1 https://app.sharelinktechnologies.com/announcement-preview/asx/8362254961f3319e39bea0d1a3bfb767
    Progress Report
2025-04-02 08:31:00 Immutep to Participate in Upcoming Investor Conferences 0 https://app.sharelinktechnologies.com/announcement-preview/asx/4435ddb36cf7041058df465cfa647805
    Company Administration - Other
2025-04-03 14:31:00 Application for quotation of securities - IMM 0 https://app.sharelinktechnologies.com/announcement-preview/asx/0edac415eea565880d062cb3ccb63724
    Appendix 2A (Application for Quotation of Securities
2025-04-08 15:31:00 Change of Director's Interest Notice F Triebel 0 https://app.sharelinktechnologies.com/announcement-preview/asx/35e707499eaa3f7bb2e19947849d4fd2
    Change of Director's Interest Notice
2025-04-08 15:32:00 Change of Director's Interest Notice - M Voigt 0 https://app.sharelinktechnologies.com/announcement-preview/asx/d2ca570fe3bf29729cb21aee1d1aa7eb
    Change of Director's Interest Notice
2025-04-11 08:20:00 Change in substantial holding 0 https://app.sharelinktechnologies.com/announcement-preview/asx/08ec4d827a686accd59f0fd9b4572d0c
    Change in substantial holding
2025-04-23 10:24:00 Immutep Investor Update 0 https://app.sharelinktechnologies.com/announcement-preview/asx/9be095e492507dee2d4e7565ccd37504
    Periodic Reports - Other
    Progress Report
2025-04-29 09:02:00 Immutep Quarterly Activities Report and Appendix 4C 1 https://app.sharelinktechnologies.com/announcement-preview/asx/8e27d8987e61776ab70a18fd64f28e37
    Commitments Test Entity - Third Quarter Report
    Commitments Test Entity - Third Quarter Activity Report
2025-05-01 16:36:00 Change in substantial holding 0 https://app.sharelinktechnologies.com/announcement-preview/asx/1e0b7ef777dc6073ef65cff60f977e4e
    Change in substantial holding
2025-05-05 08:22:00 Excellent Overall Survival in Head & Neck Cancer Patients 1 https://app.sharelinktechnologies.com/announcement-preview/asx/36f8811db1b59c48b4549d2db987bc75
    Progress Report
2025-05-15 08:16:00 High Response Rates achieved in Lung Cancer in INSIGHT-003 1 https://app.sharelinktechnologies.com/announcement-preview/asx/25674bf2c027d02adf5b0391c946f6e0
    Progress Report
2025-05-26 08:22:00 Primary Endpoint Met in Phase II Soft Tissue Sarcoma Trial 1 https://app.sharelinktechnologies.com/announcement-preview/asx/022d943cb0ccdc552f73e678bb1c2ac6
    Progress Report
2025-06-02 08:21:00 Immutep Corporate Presentation 0 https://app.sharelinktechnologies.com/announcement-preview/asx/e044181c5420c4410593b0f1f2b592f1
    Company Presentation
2025-06-23 08:33:00 Update on Phase I Study of IMP761 for Autoimmune Diseases 1 https://app.sharelinktechnologies.com/announcement-preview/asx/6cc1a51e0fc0dfec5e549e3968c33615
    Progress Report
2025-06-30 16:39:00 Change in substantial holding 0 https://app.sharelinktechnologies.com/announcement-preview/asx/2f22af211e20703475c7408565897810
    Change in substantial holding
2025-07-17 08:19:00 Change in substantial holding 0 https://app.sharelinktechnologies.com/announcement-preview/asx/8e3039aa74e94fc098b7c624b9634195
    Change in substantial holding
2025-07-18 12:09:00 Application for quotation of securities - IMM 0 https://app.sharelinktechnologies.com/announcement-preview/asx/860d8ab027ed1eb84114647506366b60
    Appendix 2A (Application for Quotation of Securities
2025-07-18 12:10:00 Application for quotation of securities - IMM 0 https://app.sharelinktechnologies.com/announcement-preview/asx/4cca40a473e63ea8d387c8f7ca4a1da9
    Appendix 2A (Application for Quotation of Securities
2025-07-23 17:40:00 Ceasing to be a substantial holder 0 https://app.sharelinktechnologies.com/announcement-preview/asx/f74cd49d41da47a262c7e2a14e8f0f84
    Ceasing to be a substantial holder
2025-07-25 08:16:00 Ceasing to be a substantial holder 0 https://app.sharelinktechnologies.com/announcement-preview/asx/673819b97b0242aeab69b28389a15751
    Ceasing to be a substantial holder
2025-07-28 09:27:00 Abstracts Accepted for Presentation at ESMO Congress 2025 0 https://app.sharelinktechnologies.com/announcement-preview/asx/17b5c52cd0b1366f90430c0dc8693171
    Progress Report
2025-07-29 08:21:00 TACTI-004 trial in progress poster to be presented at WCLC 0 https://app.sharelinktechnologies.com/announcement-preview/asx/a3acb8e1ab1cdd5a8aef4716e0a8c79d
    Progress Report
2025-07-30 08:25:00 Immutep Quarterly Activities Report and Appendix 4C 1 https://app.sharelinktechnologies.com/announcement-preview/asx/85e76cc941a5fdde0087c0d15d61a485
    Commitments Test Entity - Fourth Quarter Report
    Commitments Test Entity - Fourth Quarter Activity Report
2025-08-05 09:26:00 FDA feedback received for head & neck cancer in CPS below 1 1 https://app.sharelinktechnologies.com/announcement-preview/asx/79a2f52415da02bb80ed293967f9bbed
    Progress Report
2025-08-29 09:30:00 Appendix 4E & 2025 Full Year Statutory Accounts 1 https://app.sharelinktechnologies.com/announcement-preview/asx/3692074a8c500b2191b4bf70eb82a21f
    Annual Report
    Top 20 shareholders
    Preliminary Final Report
    Full Year Accounts
    Full Year Audit Review
    Full Year Directors' Statement
    Full Year Directors' Report
2025-09-08 09:04:00 EFTISARC-NEO data accepted for oral presentation at CTOS 0 https://app.sharelinktechnologies.com/announcement-preview/asx/724c96b6131ee1f32648ad569824ae31
    Progress Report
2025-09-12 08:18:00 Becoming a substantial holder 0 https://app.sharelinktechnologies.com/announcement-preview/asx/e238a417f36471b09b088f6edf37ba78
    Becoming a substantial holder
2025-09-22 08:21:00 New investigator-initiated Phase II trial for Efti 1 https://app.sharelinktechnologies.com/announcement-preview/asx/130221a7de24e05e461fc13068dac3af
    Progress Report
2025-10-01 14:58:00 Application for quotation of securities - IMM 0 https://app.sharelinktechnologies.com/announcement-preview/asx/de6fffc06631b344155f55582921094f
    Appendix 2A (Application for Quotation of Securities
2025-10-08 10:00:00 Change of Director's Interest Notice - M Voigt 0 https://app.sharelinktechnologies.com/announcement-preview/asx/0d36d6c080aebafd870634652ac892bc
    Change of Director's Interest Notice
2025-10-08 10:01:00 Change of Director's Interest Notice - F Triebel 0 https://app.sharelinktechnologies.com/announcement-preview/asx/bd06d641532ec1e23a19f01f773c0ab9
    Change of Director's Interest Notice
2025-10-08 10:03:00 Change of Director's Interest Notice - P Meyers 0 https://app.sharelinktechnologies.com/announcement-preview/asx/1cb27a17b773089899e9e72e5ae73264
    Change of Director's Interest Notice
2025-10-09 08:35:00 TACTI-004 (KEYNOTE-F91) Phase 3 update in First Line NSCLC 1 https://app.sharelinktechnologies.com/announcement-preview/asx/2050bb2b02f8fa9162fc9ea59e7f3239
    Progress Report
2025-10-13 08:25:00 Successful Completion of FDA Project Optimus Requirements 1 https://app.sharelinktechnologies.com/announcement-preview/asx/80a3b4953c65e5707ce4724447e9077b
    Progress Report
2025-10-13 20:20:00 Notification regarding unquoted securities - IMM 0 https://app.sharelinktechnologies.com/announcement-preview/asx/48d6715fad9423bf66e58bc20d823f1f
    Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
2025-10-15 08:32:00 2025 Annual General Meeting and Key Dates 0 https://app.sharelinktechnologies.com/announcement-preview/asx/dd2873478378bff638d8195d8f46b813
    Notice of Meeting - Other
2025-10-20 08:17:00 Improved ORR in First Line NSCLC - presented at ESMO 2025 1 https://app.sharelinktechnologies.com/announcement-preview/asx/9e3cecc01503a8643dd9a87863fb8c27
    Progress Report
2025-10-20 08:17:00 Primary Endpoint Met in STS Trial - presented at ESMO 2025 1 https://app.sharelinktechnologies.com/announcement-preview/asx/16b86eb49ced1e02a2c0cdef1c1828f3
    Progress Report
2025-10-24 08:31:00 Notice of Annual General Meeting/Proxy Form 0 https://app.sharelinktechnologies.com/announcement-preview/asx/5d494914493cc375843f4ef4a6b4bd25
    Notice of Annual General Meeting
    Proxy Form
2025-10-24 08:31:00 Appendix 4G and Corporate Governance Statement 0 https://app.sharelinktechnologies.com/announcement-preview/asx/e59ce7ad5282a68b89e1538cdad28586
    Corporate Governance
    Takeover - Appendix 4G
2025-10-24 08:31:00 Annual Report to shareholders 0 https://app.sharelinktechnologies.com/announcement-preview/asx/758ea95ebd6316fd2178f0a90ce47068
    Annual Report
    Top 20 shareholders
    Full Year Accounts
    Full Year Audit Review
    Full Year Directors' Statement
    Full Year Directors' Report
2025-10-27 08:15:00 Annual Report filed on Form 20-F 0 https://app.sharelinktechnologies.com/announcement-preview/asx/0c29c50ce1ea8ea2e7ea2481e2a1afcd
    Annual Report
2025-10-29 08:22:00 Immutep Quarterly Activities Report and Appendix 4C 1 https://app.sharelinktechnologies.com/announcement-preview/asx/a505885e7c3977a20c051fd9661370e1
    Commitments Test Entity - First Quarter Report
    Commitments Test Entity - First Quarter Activity Report
2025-11-03 09:28:00 Immutep Receives A$4.6 million French R&D Tax Incentive 1 https://app.sharelinktechnologies.com/announcement-preview/asx/b2e26cf487375d6febef63a4fd36e66a
    Periodic Reports - Other
2025-11-13 08:18:00 EFTISARC-NEO Phase II results presented at CTOS 2025 1 https://app.sharelinktechnologies.com/announcement-preview/asx/fd6bb061b4acfeeb3fa07b5e8b2a4137
    Progress Report
2025-11-27 10:47:00 Immutep AGM 2025 - CEO's Presentation 0 https://app.sharelinktechnologies.com/announcement-preview/asx/9b799a3a174feab42438009e64c92abb
    Company Presentation
    Chairman's Address to Shareholders
2025-11-27 10:51:00 Immutep AGM 2025 - Chairman's Address 0 https://app.sharelinktechnologies.com/announcement-preview/asx/62d13d15f84fc80441ace162523727cc
    Chairman's Address to Shareholders
2025-11-27 13:13:00 Results of Meeting 0 https://app.sharelinktechnologies.com/announcement-preview/asx/1ea822e1e19c65d85b515068bcf19505
    Results of Meeting
2025-12-02 09:29:00 New data presentation from AIPAC-003 Phase II for SABCS 1 https://app.sharelinktechnologies.com/announcement-preview/asx/0aa295d891258b391aa7cca1ea329f52
    Progress Report
2025-12-02 11:56:00 Notification regarding unquoted securities - IMM 0 https://app.sharelinktechnologies.com/announcement-preview/asx/c8b4e99250708cd2e90319aa6cab9450
    Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
2025-12-05 09:56:00 Application for quotation of securities - IMM 0 https://app.sharelinktechnologies.com/announcement-preview/asx/7687646ed9c0844d7a0b3a2ddc8a6322
    Appendix 2A (Application for Quotation of Securities
2025-12-05 19:27:00 Change of Director's Interest Notice - L Boyce 0 https://app.sharelinktechnologies.com/announcement-preview/asx/2cfbdfeeb72829be3e5edf41d09ff936
    Change of Director's Interest Notice
2025-12-05 19:28:00 Change of Director's Interest Notice - P Meyers 0 https://app.sharelinktechnologies.com/announcement-preview/asx/08446eafb740306bfcee8a4d9c3dad3c
    Change of Director's Interest Notice
2025-12-05 19:34:00 Change of Director's Interest Notice - R Howard 0 https://app.sharelinktechnologies.com/announcement-preview/asx/b1ab1479d874acb709093bbb4b424e7b
    Change of Director's Interest Notice
2025-12-08 18:24:00 Immutep enters into Strategic Collaboration with Dr. Reddy's 1 https://app.sharelinktechnologies.com/announcement-preview/asx/1aff0654d4d41f37ef9360f8d79fe025
    Progress Report
2025-12-16 08:34:00 TACTI-004 phase III trial enrolment continues at robust pace 1 https://app.sharelinktechnologies.com/announcement-preview/asx/d460ba2855219990b21ee0266b7c80ae
    Progress Report
2025-12-22 08:25:00 Positive Update on IMP761 Phase 1 1 https://app.sharelinktechnologies.com/announcement-preview/asx/34ece55fd29897c84f6ea2f63e7f6408
    Progress Report
2025-12-31 08:27:00 Change in substantial holding 0 https://app.sharelinktechnologies.com/announcement-preview/asx/5d1b84298a0e8076630727ec39842e05
    Change in substantial holding
Powered by Share Link